Asahi Intecc Reports Strong Sales Growth Amid Challenges

Asahi Intecc Co ( (AHICF) ) has released its Q4 earnings. Here is a breakdown of the information Asahi Intecc Co presented to its investors.

Asahi Intecc Co., Ltd. is a Japanese company listed on the Tokyo and Nagoya Stock Exchanges, specializing in the development, manufacturing, and sales of medical devices and components, with a focus on the cardiovascular field.

In its latest earnings report for the fiscal year ending June 30, 2025, Asahi Intecc Co. reported a significant increase in net sales and operating profit, driven by strong performance in its Medical Division both domestically and internationally. However, the company faced a decline in profit attributable to owners of the parent due to extraordinary losses.

The company achieved net sales of 120,025 million yen, marking an 11.6% increase year-on-year, and an operating profit of 30,079 million yen, a 35.9% rise from the previous year. The Medical Division saw a 12.7% increase in net sales, bolstered by market share expansion, while the Device Division experienced a modest 3.0% growth. Despite these gains, profit attributable to owners of the parent decreased by 19.4% to 12,737 million yen, primarily due to extraordinary losses.

Looking forward, Asahi Intecc Co. aims to continue its growth trajectory with a new medium-term management plan, “Building the Future 2030,” focusing on enhancing corporate value through strategic global market development and R&D expansion. The company forecasts a 9.0% increase in net sales for the fiscal year ending June 30, 2026, with a significant rebound in profit attributable to owners of the parent.

Overall, Asahi Intecc Co. remains committed to expanding its market presence and improving its financial performance, leveraging its strengths in the medical device sector to drive future growth.